1 false false false false false false false false false false true false false false false false false No description of principal activity 2023-11-01 Sage Accounts Production Advanced 2023 - FRS102_2023 7,586 109,506 100 100 100 xbrli:pure xbrli:shares iso4217:GBP 09249457 2023-11-01 2024-10-31 09249457 2024-10-31 09249457 2023-10-31 09249457 2022-11-01 2023-10-31 09249457 2023-10-31 09249457 2022-10-31 09249457 core:FurnitureFittings 2023-11-01 2024-10-31 09249457 bus:RegisteredOffice 2023-11-01 2024-10-31 09249457 bus:LeadAgentIfApplicable 2023-11-01 2024-10-31 09249457 bus:Director1 2023-11-01 2024-10-31 09249457 core:FurnitureFittings 2024-10-31 09249457 core:WithinOneYear 2024-10-31 09249457 core:WithinOneYear 2023-10-31 09249457 core:RetainedEarningsAccumulatedLosses 2023-10-31 09249457 core:RetainedEarningsAccumulatedLosses 2022-10-31 09249457 core:RetainedEarningsAccumulatedLosses 2024-10-31 09249457 core:RetainedEarningsAccumulatedLosses 2023-10-31 09249457 core:ShareCapital 2024-10-31 09249457 core:ShareCapital 2023-10-31 09249457 core:CostValuation core:Non-currentFinancialInstruments 2024-10-31 09249457 core:Non-currentFinancialInstruments 2024-10-31 09249457 core:Non-currentFinancialInstruments 2023-10-31 09249457 bus:Director1 2023-10-31 09249457 bus:Director1 2024-10-31 09249457 bus:Director1 2022-10-31 09249457 bus:Director1 2023-10-31 09249457 bus:Director1 2022-11-01 2023-10-31 09249457 bus:SmallEntities 2023-11-01 2024-10-31 09249457 bus:AuditExemptWithAccountantsReport 2023-11-01 2024-10-31 09249457 bus:SmallCompaniesRegimeForAccounts 2023-11-01 2024-10-31 09249457 bus:PrivateLimitedCompanyLtd 2023-11-01 2024-10-31 09249457 bus:FullAccounts 2023-11-01 2024-10-31
COMPANY REGISTRATION NUMBER: 09249457
Regent Square Limited
Unaudited Financial Statements
For the Year Ended
31 October 2024
Regent Square Limited
Financial Statements
Year Ended 31st October 2024
Contents
Pages
Officers and Professional Advisers
1
Director's Report
2
Chartered Accountant's Report to the Director on the Preparation of the Unaudited Statutory Financial Statements
3
Statement of Income and Retained Earnings
4
Statement of Financial Position
5
Notes to the Financial Statements
6 to 10
Regent Square Limited
Officers and Professional Advisers
Director
Mr J Nash
Registered Office
103 London Road
Braintree
Essex
CM7 2LF
Accountants
Peyton Tyler Mears
Chartered accountants
Middleborough House
16 Middleborough
Colchester
Essex
CO1 1QT
Bankers
Barclays Bank Plc
PO Box 3692
Witham
Essex
CM8 2AT
Regent Square Limited
Director's Report
Year Ended 31st October 2024
The director presents his report and the unaudited financial statements of the company for the year ended 31 October 2024 .
Incorporation
The company was incorporated on the 6th October 2014 and commenced trading on the 20th November 2014.
Director
The director who served the company during the year was as follows:
Mr J Nash
Small Company Provisions
This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies exemption.
This report was approved by the board of directors on 19 March 2025 and signed on behalf of the board by:
Mr J Nash
Director
Regent Square Limited
Chartered Accountant's Report to the Director on the Preparation of the Unaudited Statutory Financial Statements of Regent Square Limited
Year Ended 31st October 2024
As described on the statement of financial position, the director of the company is responsible for the preparation of the financial statements for the year ended 31st October 2024, which comprise the statement of income and retained earnings, statement of financial position and the related notes. You consider that the company is exempt from an audit under the Companies Act 2006. In accordance with your instructions we have compiled these financial statements in order to assist you to fulfil your statutory responsibilities, from the accounting records and from information and explanations supplied to us.
Peyton Tyler Mears Chartered accountants
Middleborough House 16 Middleborough Colchester Essex CO1 1QT
19 March 2025
Regent Square Limited
Statement of Income and Retained Earnings
Year Ended 31st October 2024
2024
2023
Note
£
£
Turnover
80,000
Cost of sales
80,000
87,831
--------
--------
Gross Loss
( 87,831)
Administrative expenses
7,586
18,675
-------
---------
Operating Loss
( 7,586)
( 106,506)
Interest payable and similar expenses
5
3,000
-------
---------
Loss Before Taxation
( 7,586)
( 109,506)
Tax on loss
-------
---------
Loss for the Financial Year and Total Comprehensive Income
( 7,586)
( 109,506)
-------
---------
Retained Earnings at the Start of the Year
203,845
313,351
---------
---------
Retained Earnings at the End of the Year
196,259
203,845
---------
---------
All the activities of the company are from continuing operations.
Regent Square Limited
Statement of Financial Position
31 October 2024
2024
2023
Note
£
£
£
Fixed Assets
Investments
7
100
100
Current Assets
Stocks
80,000
Debtors
8
232,164
376,328
Cash at bank and in hand
2,476
2,239
---------
---------
234,640
458,567
Creditors: amounts falling due within one year
9
38,480
254,821
---------
---------
Net Current Assets
196,160
203,746
---------
---------
Total Assets Less Current Liabilities
196,260
203,846
---------
---------
Net Assets
196,260
203,846
---------
---------
Capital and Reserves
Called up share capital
1
1
Profit and loss account
196,259
203,845
---------
---------
Shareholder Funds
196,260
203,846
---------
---------
These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
For the year ending 31st October 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 19 March 2025 , and are signed on behalf of the board by:
Mr J Nash
Director
Company registration number: 09249457
Regent Square Limited
Notes to the Financial Statements
Year Ended 31st October 2024
1. General Information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 103 London Road, Braintree, Essex, CM7 2LF.
2. Statement of Compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting Policies
Basis of Preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Revenue Recognition
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Tangible Assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in equity, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation, is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in equity in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in equity in respect of that asset, the excess shall be recognised in profit or loss.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Fixtures and Fittings
-
15% straight line
Equipment
-
33% straight line
Investments
Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses.
Listed investments are measured at fair value with changes in fair value being recognised in profit or loss.
Investments in Associates
Investments in associates accounted for in accordance with the cost model are recorded at cost less any accumulated impairment losses. Investments in associates accounted for in accordance with the fair value model are initially recorded at the transaction price. At each reporting date, the investments are measured at fair value, with changes in fair value recognised in other comprehensive income/profit or loss. Where it is impracticable to measure fair value reliably without undue cost or effort, the cost model will be adopted. Dividends and other distributions received from the investment are recognised as income without regard to whether the distributions are from accumulated profits of the associate arising before or after the date of acquisition.
Investments in Joint Ventures
Investments in jointly controlled entities accounted for in accordance with the cost model are recorded at cost less any accumulated impairment losses. Investments in jointly controlled entities accounted for in accordance with the fair value model are initially recorded at the transaction price. At each reporting date, the investments are measured at fair value, with changes in fair value recognised in other comprehensive income/profit or loss. Where it is impracticable to measure fair value reliably without undue cost or effort, the cost model will be adopted. Dividends and other distributions received from the investment are recognised as income without regard to whether the distributions are from accumulated profits of the joint venture arising before or after the date of acquisition.
Impairment of Fixed Assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.
Stocks
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stock to its present location and condition.
Financial Instruments
A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment. Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship.
Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets are either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
4. Employee Numbers
The average number of persons employed by the company during the year amounted to 1 (2023: 1 ).
5. Interest Payable and Similar Expenses
2024
2023
£
£
Other interest payable and similar charges
3,000
----
-------
6. Tangible Assets
Fixtures and fittings
Equipment
Total
£
£
£
Cost
At 1st November 2023 and 31st October 2024
2,283
2,368
4,651
-------
-------
-------
Depreciation
At 1st November 2023 and 31st October 2024
2,283
2,368
4,651
-------
-------
-------
Carrying amount
At 31st October 2024
-------
-------
-------
At 31st October 2023
-------
-------
-------
7. Investments
Shares in group undertakings
£
Cost
At 1st November 2023 and 31st October 2024
100
----
Impairment
At 1st November 2023 and 31st October 2024
----
Carrying amount
At 31st October 2024
100
----
At 31st October 2023
100
----
8. Debtors
2024
2023
£
£
Other debtors
232,164
376,328
---------
---------
9. Creditors: amounts falling due within one year
2024
2023
£
£
Social security and other taxes
524
Other creditors
38,480
254,297
--------
---------
38,480
254,821
--------
---------
10. Director's Advances, Credits and Guarantees
During the year the director entered into the following advances and credits with the company:
2024
Balance brought forward
Advances/ (credits) to the director
Amounts repaid
Balance outstanding
£
£
£
£
Mr J Nash
( 251,472)
( 11,899)
227,716
( 35,655)
---------
--------
---------
--------
2023
Balance brought forward
Advances/ (credits) to the director
Amounts repaid
Balance outstanding
£
£
£
£
Mr J Nash
( 234,284)
( 17,188)
( 251,472)
---------
--------
----
---------